SELP and cancer: Regarding complications, P-selectin levels have shown no differences between patients with and without post-thrombotic syndrome (PTS) 51 months after DVT [72] and were not associated with VTE recurrence during a six-month follow-up in 900 patients with cancer and acute VTE [60].